News

Sersense joins Mayo Clinic in a collaborative effort to develop a revolutionary inflammatory disease treatment funded by ARPA-H

Sersense, Inc. has been selected to participate in a groundbreaking research project led by Mayo Clinic. The initiative, funded by an ARPA-H with an award of up to $42.8 million, aims to create an implantable "living pharmacy" to treat inflammatory diseases such as Crohn's disease and ulcerative colitis.

Oct 07, 2024

Sersense awarded with a Launch Minnesota Business Operation Innovation Grant

Sersense, Inc. has been awarded an Innovation Grant by LaunchMN and the Minnesota Employment and Economic Development to support the current development of our cutting-edge point-of-care diagnostic tools.

Read more: https://mn.gov/deed/newscenter/press-releases/index.jsp?id=1045-672279

Mar 12, 2025

Read more: https://newsnetwork.mayoclinic.org/discussion/mayo-clinic-secures-arpa-h-award-to-build-a-living-pharmacy-within-the-body-for-inflammatory-disease/

Illustration by Alan Gonzalez Suarez